News

A year ago, Epicentre, together with MSF teams in the DRC, launched a large-scale study to better understand the impact of preventive oral vaccination...

On 30 June and 1 July, a workshop on tuberculosis was held at Epicentre's Mbarara Research Centre. The Centre has extensive experience in TB research ...

While everyone agrees that by responding quickly and locally to the appearance of new cases of cholera, the chances of stopping the epidemic or at lea...

Epicentre’s contribution to addressing TB diagnostics and therapeutics gaps in Low Income Countries

Discover how throughout 2021 Epicentre has provided feasible, concrete and appropriate responses for better preventive, diagnostic or therapeutic medi...

A joint MSF and South African Department of Health HIV program in KwaZulu-Natal is one of the first in the country to achieve the ambitious UNAIDS 90-...

Niger, with Epicentre as project leader, officially joins the Organization for Women in Science for the Developing World in Niger.

After years of progress, the fight against malaria has slowed down in 2020. For the first time in 20 years, the number of cases has increased, most li...

During this webinar, on 10 May at 11am (Paris Time) on Zoom in French and English, you will discover the results of the survey on vaccination coverage...

Two recent drugs, bedaquiline and delamanid, are changing the game for patients with multidrug-resistant tuberculosis. Two studies of the endTB consor...